Cite
Dourthe ME, Rabian F, Yakouben K, et al. Determinants of CD19-positive vs CD19-negative relapse after tisagenlecleucel for B-cell acute lymphoblastic leukemia. Leukemia. 2021;35(12):3383-3393doi: 10.1038/s41375-021-01281-7.
Dourthe, M. E., Rabian, F., Yakouben, K., Chevillon, F., Cabannes-Hamy, A., Méchinaud, F., Grain, A., Chaillou, D., Rahal, I., Caillat-Zucman, S., Lesprit, E., Naudin, J., Roupret-Serzec, J., Parquet, N., Brignier, A., Guérin-El Khourouj, V., Lainey, E., Caye-Eude, A., Cavé, H., Clappier, E., Mathis, S., Azoulay, E., Dalle, J. H., Dhédin, N., Madelaine, I., Larghero, J., Boissel, N., & Baruchel, A. (2021). Determinants of CD19-positive vs CD19-negative relapse after tisagenlecleucel for B-cell acute lymphoblastic leukemia. Leukemia, 35(12), 3383-3393. https://doi.org/10.1038/s41375-021-01281-7
Dourthe, Marie-Emilie, et al. "Determinants of CD19-positive vs CD19-negative relapse after tisagenlecleucel for B-cell acute lymphoblastic leukemia." Leukemia vol. 35,12 (2021): 3383-3393. doi: https://doi.org/10.1038/s41375-021-01281-7
Dourthe ME, Rabian F, Yakouben K, Chevillon F, Cabannes-Hamy A, Méchinaud F, Grain A, Chaillou D, Rahal I, Caillat-Zucman S, Lesprit E, Naudin J, Roupret-Serzec J, Parquet N, Brignier A, Guérin-El Khourouj V, Lainey E, Caye-Eude A, Cavé H, Clappier E, Mathis S, Azoulay E, Dalle JH, Dhédin N, Madelaine I, Larghero J, Boissel N, Baruchel A. Determinants of CD19-positive vs CD19-negative relapse after tisagenlecleucel for B-cell acute lymphoblastic leukemia. Leukemia. 2021 Dec;35(12):3383-3393. doi: 10.1038/s41375-021-01281-7. Epub 2021 May 17. PMID: 34002027.
Copy
Download .nbib